These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17206072)

  • 1. Antibiotic therapy: a major cause of drug-induced jaundice in southwest England.
    Hussaini SH; O'Brien CS; Despott EJ; Dalton HR
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):15-20. PubMed ID: 17206072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug associated hepatic reactions in New Zealand: 21 years experience.
    Pillans PI
    N Z Med J; 1996 Aug; 109(1028):315-9. PubMed ID: 8816722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jaundice due to anti-tuberculous drugs--a dose related phenomenon.
    Mirchandani LV; Joshi JM
    J Assoc Physicians India; 1995 Nov; 43(11):767-9. PubMed ID: 8773037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-amoxiclav jaundice: clinical and histological features and HLA class II association.
    O'Donohue J; Oien KA; Donaldson P; Underhill J; Clare M; MacSween RN; Mills PR
    Gut; 2000 Nov; 47(5):717-20. PubMed ID: 11034591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in post-operative acute kidney injury following a change in antibiotic prophylaxis policy for orthopaedic surgery: an observational study.
    Walker H; Patton A; Bayne G; Marwick C; Sneddon J; Davey P; Nathwani D; Bell S
    J Antimicrob Chemother; 2016 Sep; 71(9):2598-605. PubMed ID: 27231276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-amoxiclav-induced acute generalized exanthematous pustulosis confirmed by patch testing.
    Harries MJ; McIntyre SJ; Kingston TP
    Contact Dermatitis; 2006 Dec; 55(6):372. PubMed ID: 17101020
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of actinomycetoma due to Nocardia spp. with amoxicillin-clavulanate.
    Bonifaz A; Flores P; Saúl A; Carrasco-Gerard E; Ponce RM
    Br J Dermatol; 2007 Feb; 156(2):308-11. PubMed ID: 17223871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study.
    Wing K; Bhaskaran K; Pealing L; Root A; Smeeth L; van Staa TP; Klungel OH; Reynolds RF; Douglas I
    J Antimicrob Chemother; 2017 Sep; 72(9):2636-2646. PubMed ID: 28859440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
    Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
    Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Falls in English and Welsh hospitals: a national observational study based on retrospective analysis of 12 months of patient safety incident reports.
    Healey F; Scobie S; Oliver D; Pryce A; Thomson R; Glampson B
    Qual Saf Health Care; 2008 Dec; 17(6):424-30. PubMed ID: 19064657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute psychosis caused by co-amoxiclav.
    Bell CL; Watson B; Waring WS
    BMJ; 2008 Oct; 337():a2117. PubMed ID: 18945734
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
    Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency department visits for antibiotic-associated adverse events.
    Shehab N; Patel PR; Srinivasan A; Budnitz DS
    Clin Infect Dis; 2008 Sep; 47(6):735-43. PubMed ID: 18694344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic assessment of co-amoxiclav in the treatment of melioidosis.
    Chierakul W; Wangboonskul J; Singtoroj T; Pongtavornpinyo W; Short JM; Maharjan B; Wuthiekanun V; Dance DA; Teparrukkul P; Lindegardh N; Peacock SJ; Day NP; Chaowagul W; White NJ
    J Antimicrob Chemother; 2006 Dec; 58(6):1215-20. PubMed ID: 17003061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flucloxacillin associated neutropenia in children treated for bone and joint infections.
    van den Boom J; Kristiansen JB; Voss LM; Stott NS
    J Paediatr Child Health; 2005; 41(1-2):48-51. PubMed ID: 15670224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy.
    Salvo F; Polimeni G; Moretti U; Conforti A; Leone R; Leoni O; Motola D; Dusi G; Caputi AP
    J Antimicrob Chemother; 2007 Jul; 60(1):121-6. PubMed ID: 17449881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
    Tunçcan OG; Ulutan F; Karakuş R
    Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flucloxacillin induced acute renal failure.
    Xu B; Murray M
    Aust Fam Physician; 2008 Dec; 37(12):1009-11. PubMed ID: 19142275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported antibiotic allergy incidence and prevalence: age and sex effects.
    Macy E; Poon K-Y T
    Am J Med; 2009 Aug; 122(8):778.e1-7. PubMed ID: 19635279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium.
    Martin M; Moore L; Quilici S; Decramer M; Simoens S
    Curr Med Res Opin; 2008 Mar; 24(3):737-51. PubMed ID: 18230196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.